Egis in the World

Our products reach 100 countries

Click here to learn more

Pharma Company

Egis activities extend to every field of the pharmaceutical value chain

Click here to learn more

Research & Development

Innovation is one of the pillars of our strategy. We devoted EUR 48 million to research and development in the 2022/2023 business year.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners

Egis in the World

Egis products reach 100 countries around the world.

Egis’ products reach 100 countries. Our portfolio consists of 653 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. These contents are available with password protection - please contact our representative or require your own account at the Contact menu.

Learn more
Main therapic areas
Main therapic areas
Allergology
Anti inflammatory
Cardiovascular system
Central nervous system
Diabetology
Gastroenterology
Oncology
Women´s health
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox